Ghost-Tree-Capital

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AXSM",
  "ASND",
  "EWTX",
  "INSM",
  "ABSI",
  "TGTX",
  "APLS",
  "RGNX",
  "ARVN",
  "ANNX",
  "OLMA",
  "CATX",
  "SVRA",
  "TSHA",
  "NUVB",
  "SMMT",
  "LRMR",
  "REPL",
  "PHAT",
  "SNDX",
  "NGNE",
  "AMLX",
  "JANX",
  "SYRE",
  "TARS",
  null,
  "KRRO",
  "PRQR",
  "TNYA",
  "ATYR",
  "RZLT",
  "RYTM",
  "MLTX",
  "SLNO",
  "DYN",
  "SRPT",
  "ROIV",
  null,
  null,
  "CRVS",
  "NVO",
  "VKTX",
  "VRDN",
  "IMVT",
  "PCVX",
  null,
  "BPMC",
  "BBIO",
  "CAPR",
  "CGON",
  "CRBP",
  "CRNX"
]

Filing Details

13F-HR • 2024-09-30

SEC FilingSEC DataHachi Filing

Report Date: 2024-09-30
Filing Date: 2024-11-14
Total Holdings: 52
Total Value: 322268332
Accession Number: 0001420506-24-002434
Form Type: 13F-HR
CIK: ghost-tree-capital
Manager Name: Ghost-Tree-Capital

Data Enrichment

92% identified

48 identified4 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

52 positions • $322.3M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 3

Sort by:

78464A870

Shares:300.0K

Value:$29.6M

% of Portfolio:9.2% ($29.6M/$322.3M)

G1110E907

Shares:348.8K

Value:$17.4M

% of Portfolio:5.4% ($17.4M/$322.3M)

Sarepta Therapeutics, Inc.

SRPT|803607100

Shares:120.0K

Value:$15.0M

% of Portfolio:4.7% ($15.0M/$322.3M)

NOVO NORDISK A S

NVO|670100205

Shares:110.0K

Value:$13.1M

% of Portfolio:4.1% ($13.1M/$322.3M)

Blueprint Medicines Corp

BPMC|09627Y109

Shares:140.0K

Value:$12.9M

% of Portfolio:4.0% ($12.9M/$322.3M)

Axsome Therapeutics, Inc.

AXSM|05464T104

Shares:135.0K

Value:$12.1M

% of Portfolio:3.8% ($12.1M/$322.3M)

Tarsus Pharmaceuticals, Inc.

TARS|87650L103

Shares:350.0K

Value:$11.5M

% of Portfolio:3.6% ($11.5M/$322.3M)

Perspective Therapeutics, Inc.

CATX|46489V302

Shares:750.0K

Value:$10.0M

% of Portfolio:3.1% ($10.0M/$322.3M)

CG Oncology, Inc.

CGON|156944100

Shares:250.0K

Value:$9.4M

% of Portfolio:2.9% ($9.4M/$322.3M)

Roivant Sciences Ltd.

ROIV|G76279101

Shares:800.0K

Value:$9.2M

% of Portfolio:2.9% ($9.2M/$322.3M)

Vaxcyte, Inc.

PCVX|92243G108

Shares:80.0K

Value:$9.1M

% of Portfolio:2.8% ($9.1M/$322.3M)

Viking Therapeutics, Inc.

VKTX|92686J106

Shares:140.0K

Value:$8.9M

% of Portfolio:2.8% ($8.9M/$322.3M)

Syndax Pharmaceuticals Inc

SNDX|87164F105

Shares:450.0K

Value:$8.7M

% of Portfolio:2.7% ($8.7M/$322.3M)

Janux Therapeutics, Inc.

JANX|47103J105

Shares:190.0K

Value:$8.6M

% of Portfolio:2.7% ($8.6M/$322.3M)

Ascendis Pharma A/S

ASND|04351P101

Shares:52.5K

Value:$7.8M

% of Portfolio:2.4% ($7.8M/$322.3M)

Crinetics Pharmaceuticals, Inc.

CRNX|22663K107

Shares:150.0K

Value:$7.7M

% of Portfolio:2.4% ($7.7M/$322.3M)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:150.0K

Value:$7.6M

% of Portfolio:2.4% ($7.6M/$322.3M)

TG THERAPEUTICS, INC.

TGTX|88322Q108

Shares:310.0K

Value:$7.3M

% of Portfolio:2.2% ($7.3M/$322.3M)

Rezolute, Inc.

RZLT|76200L309

Shares:1.5M

Value:$7.2M

% of Portfolio:2.2% ($7.2M/$322.3M)

Phathom Pharmaceuticals, Inc.

PHAT|71722W107

Shares:375.0K

Value:$6.8M

% of Portfolio:2.1% ($6.8M/$322.3M)

Instrument	Shares		Other Manager	Value	% of Portfolio
(cusip78464A870)✕	300.0K	QoQ NEW(+300.0K) YoY-	All Managers (Combined)	$29.6M	9.2% ($29.6M/$322.3M)	QoQ NEW(+$29.6M) YoY-
(cusipG1110E907)✕	348.8K	QoQ NEW(+348.8K) YoY-	All Managers (Combined)	$17.4M	5.4% ($17.4M/$322.3M)	QoQ NEW(+$17.4M) YoY-
Sarepta Therapeutics, Inc.(SRPTcusip803607100)	120.0K	QoQ +118.18% (+65.0K) YoY-	All Managers (Combined)	$15.0M	4.7% ($15.0M/$322.3M)	QoQ +72.46% (+$6.3M) YoY-
NOVO NORDISK A S(NVOcusip670100205)	110.0K	QoQ NEW(+110.0K) YoY-	All Managers (Combined)	$13.1M	4.1% ($13.1M/$322.3M)	QoQ NEW(+$13.1M) YoY-
Blueprint Medicines Corp(BPMCcusip09627Y109)	140.0K	QoQ +250.00% (+100.0K) YoY-	All Managers (Combined)	$12.9M	4.0% ($12.9M/$322.3M)	QoQ +200.38% (+$8.6M) YoY-
Axsome Therapeutics, Inc.(AXSMcusip05464T104)	135.0K	QoQ -10.00% (-15.0K) YoY-	All Managers (Combined)	$12.1M	3.8% ($12.1M/$322.3M)	QoQ +0.47% (-$57.5K) YoY-
Tarsus Pharmaceuticals, Inc.(TARScusip87650L103)	350.0K	QoQ +48.93% (+115.0K) YoY-	All Managers (Combined)	$11.5M	3.6% ($11.5M/$322.3M)	QoQ +80.22% (+$5.1M) YoY-
Perspective Therapeutics, Inc.(CATXcusip46489V302)	750.0K	QoQ -18.91% (-175.0K) YoY-	All Managers (Combined)	$10.0M	3.1% ($10.0M/$322.3M)	QoQ +8.56% (-$790.3K) YoY-
CG Oncology, Inc.(CGONcusip156944100)	250.0K	QoQ -3.84% (-10.0K) YoY-	All Managers (Combined)	$9.4M	2.9% ($9.4M/$322.3M)	QoQ +14.91% (-$1.2M) YoY-
Roivant Sciences Ltd.(ROIVcusipG76279101)	800.0K	QoQ -20.00% (-200.0K) YoY-	All Managers (Combined)	$9.2M	2.9% ($9.2M/$322.3M)	QoQ -12.65% (-$1.3M) YoY-
Vaxcyte, Inc.(PCVXcusip92243G108)	80.0K	QoQ -46.66% (-70.0K) YoY-	All Managers (Combined)	$9.1M	2.8% ($9.1M/$322.3M)	QoQ -19.29% (-$2.2M) YoY-
Viking Therapeutics, Inc.(VKTXcusip92686J106)	140.0K	QoQ +47.36% (+45.0K) YoY-	All Managers (Combined)	$8.9M	2.8% ($8.9M/$322.3M)	QoQ +76.00% (+$3.8M) YoY-
Syndax Pharmaceuticals Inc(SNDXcusip87164F105)	450.0K	QoQ +28.57% (+100.0K) YoY-	All Managers (Combined)	$8.7M	2.7% ($8.7M/$322.3M)	QoQ +20.55% (+$1.5M) YoY-
Janux Therapeutics, Inc.(JANXcusip47103J105)	190.0K	QoQ +280.00% (+140.0K) YoY-	All Managers (Combined)	$8.6M	2.7% ($8.6M/$322.3M)	QoQ +312.11% (+$6.5M) YoY-
Ascendis Pharma A/S(ASNDcusip04351P101)	52.5K	QoQ -39.46% (-34.2K) YoY-	All Managers (Combined)	$7.8M	2.4% ($7.8M/$322.3M)	QoQ -33.72% (-$4.0M) YoY-
Crinetics Pharmaceuticals, Inc.(CRNXcusip22663K107)	150.0K	QoQ -37.50% (-90.0K) YoY-	All Managers (Combined)	$7.7M	2.4% ($7.7M/$322.3M)	QoQ -28.69% (-$3.1M) YoY-
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	150.0K	QoQ -50.00% (-150.0K) YoY-	All Managers (Combined)	$7.6M	2.4% ($7.6M/$322.3M)	QoQ -38.12% (-$4.7M) YoY-
TG THERAPEUTICS, INC.(TGTXcusip88322Q108)	310.0K	QoQ -38.00% (-190.0K) YoY-	All Managers (Combined)	$7.3M	2.2% ($7.3M/$322.3M)	QoQ -18.48% (-$1.6M) YoY-
Rezolute, Inc.(RZLTcusip76200L309)	1.5M	QoQ +3.76% (+53.5K) YoY-	All Managers (Combined)	$7.2M	2.2% ($7.2M/$322.3M)	QoQ +17.03% (+$1.0M) YoY-
Phathom Pharmaceuticals, Inc.(PHATcusip71722W107)	375.0K	QoQ -37.50% (-225.0K) YoY-	All Managers (Combined)	$6.8M	2.1% ($6.8M/$322.3M)	QoQ +9.70% (-$600.0K) YoY-